Seeking Alpha

Oncothyreon (ONTY) agrees to pay Array BioPharma (ARRY) $10M as part of a deal to collaborate on...

Oncothyreon (ONTY) agrees to pay Array BioPharma (ARRY) $10M as part of a deal to collaborate on developing the latter's ARRY-380 molecule for treating breast and other cancers. Oncothyreon is raising the $10M by selling 5M shares and warrants for another 5M shares to BVF Partners.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|